Journal Club - Recent Additions

August - 2021

Previous Next    

Showing Journal 5 of 6

Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock

R Matthew, P Di Santo, R Jung et al New Eng J Med, 2021, 385:516-25


How do the two “inodilators”, milrinone and dobutamine compare as treatments for cardiogenic shock? Common teaching says milrinone is a more effective pulmonary vasodilator, and less arrhythmogenic. 

The DOREMI trial sets out to answer this. This is how;



Previous Comments

No Comments yet.